Cargando…

Inflammasomes and Fibrosis

Fibrosis is the final common pathway of inflammatory diseases in various organs. The inflammasomes play an important role in the progression of fibrosis as innate immune receptors. There are four main members of the inflammasomes, such as NOD-like receptor protein 1 (NLRP1), NOD-like receptor protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wen-Juan, Chen, Shu-Juan, Zhou, Shun-Chang, Wu, Su-Zhen, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226128/ https://www.ncbi.nlm.nih.gov/pubmed/34177893 http://dx.doi.org/10.3389/fimmu.2021.643149

Ejemplares similares

Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
por: Gan, Can, et al.
Publicado: (2022)

Multi‐faceted role of pyroptosis mediated by inflammasome in liver fibrosis
por: Yang, Hui, et al.
Publicado: (2022)

The Inflammasome in Times of COVID-19
por: de Rivero Vaccari, Juan Carlos, et al.
Publicado: (2020)

Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016)

NLRP3 Inflammasome and Inflammatory Bowel Disease
por: Zhen, Yu, et al.
Publicado: (2019)

The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
por: Alyaseer, Amani Abraheem Alsadiq, et al.
Publicado: (2020)

Inflammasome Meets Centrosome: Understanding the Emerging Role of Centrosome in Controlling Inflammasome Activation
por: Wu, Dandan, et al.
Publicado: (2022)

The Role of HDAC6 in Autophagy and NLRP3 Inflammasome
por: Chang, Panpan, et al.
Publicado: (2021)

Inflammasome signaling proteins as biomarkers of COVID-19
por: Hadad, Roey, et al.
Publicado: (2023)

Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis
por: He, Minjing, et al.
Publicado: (2023)

PRAK Promotes the Pathogen Clearance by Macrophage Through Regulating Autophagy and Inflammasome Activation
por: Mi, Ligu, et al.
Publicado: (2021)

Inflammasomes and Type 1 Diabetes
por: Pearson, James Alexander, et al.
Publicado: (2021)

Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages
por: Zeng, Qiong-zhen, et al.
Publicado: (2019)

Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
por: Chang, Yu-Wei, et al.
Publicado: (2021)

TLR2-Melatonin Feedback Loop Regulates the Activation of NLRP3 Inflammasome in Murine Allergic Airway Inflammation
por: Wu, Hui-Mei, et al.
Publicado: (2020)

Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
por: Lin, Ting-Yi, et al.
Publicado: (2021)

Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
por: Kantono, Melvin, et al.
Publicado: (2017)

Mechanistic Insight Into the Activation of the NLRP3 Inflammasome by Neisseria gonorrhoeae in Macrophages
por: Li, Lan-Hui, et al.
Publicado: (2019)

Non-Hematopoietic MLKL Protects Against Salmonella Mucosal Infection by Enhancing Inflammasome Activation
por: Yu, Shui-Xing, et al.
Publicado: (2018)

NLRP3 inflammasome activation in response to metals
por: Huang, Wanyi, et al.
Publicado: (2023)

NLRP3 inflammasome-induced pyroptosis in digestive system tumors
por: Wen, Jiexia, et al.
Publicado: (2023)

Inflammasome-Dependent Coagulation Activation in Sepsis
por: Wu, Runliu, et al.
Publicado: (2021)

Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
por: Wong, Wei-Ting, et al.
Publicado: (2018)

Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
por: Jiang, Qi, et al.
Publicado: (2022)

Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
por: Wang, Man, et al.
Publicado: (2023)

Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation
por: Xu, Ziwei, et al.
Publicado: (2020)

Updating the NLRC4 Inflammasome: from Bacterial Infections to Autoimmunity and Cancer
por: Wen, Jiexia, et al.
Publicado: (2021)

Membrane Cholesterol Is Crucial for Clostridium difficile Surface Layer Protein Binding and Triggering Inflammasome Activation
por: Chen, Yu, et al.
Publicado: (2020)

Inflammasomes in Inflammation-Induced Cancer
por: Lin, Chu, et al.
Publicado: (2017)

Editorial: Patho- and Physiological Roles of Inflammasomes
por: Meng, Guangxun, et al.
Publicado: (2022)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Role of NLRP3 Inflammasome in Rheumatoid Arthritis
por: Yin, Hui, et al.
Publicado: (2022)

A Synthetic Small Molecule F240B Decreases NLRP3 Inflammasome Activation by Autophagy Induction
por: Wu, Chun-Hsien, et al.
Publicado: (2020)

Bacterial Exotoxins and the Inflammasome
por: Greaney, Allison J., et al.
Publicado: (2015)

The roles of inflammasomes in cancer
por: Deng, Zihan, et al.
Publicado: (2023)

MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis
por: Yu, Wen, et al.
Publicado: (2023)

Inflammasomes in Common Immune-Related Skin Diseases
por: Tang, Lili, et al.
Publicado: (2020)

Emerging mechanisms and functions of inflammasome complexes in teleost fish
por: Chang, Ming Xian
Publicado: (2023)

ATP-Induced Inflammasome Activation and Pyroptosis Is Regulated by AMP-Activated Protein Kinase in Macrophages
por: Zha, Qing-Bing, et al.
Publicado: (2016)

Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity
por: Lin, Wen-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vj5ov42ohnuk3i9oeeogerveml